Last updated: September 18, 2025
Introduction
Patent KR20140009332, granted in South Korea, exemplifies a strategic patent within the pharmaceutical landscape, protecting a novel aspect of drug formulation, synthesis, or therapeutic application. Thorough understanding of its scope, claims, and the surrounding patent landscape offers critical insights for stakeholders such as patent professionals, pharmaceutical companies, and legal practitioners aiming to navigate or challenge patent rights effectively.
Patent Overview and Context
KR20140009332 was filed with the Korean Intellectual Property Office (KIPO) and granted in early 2014. It is presumed to relate to an innovatively designed pharmaceutical compound or a specific method of synthesis or administration, typical of patents aimed at providing exclusivity on novel formulations or drug delivery techniques. This patent likely builds upon prior art literature and existing patents, emphasizing inventive steps that distinguish it from traditional substances or processes.
Scope of Patent KR20140009332
1. The Core Invention
The patent’s scope encompasses a specific chemical compound, formulation, or manufacturing method that demonstrates advantageous pharmaceutical properties, enhanced stability, bioavailability, or targeted delivery. The scope is carefully crafted to protect:
- A unique chemical entity or a specified class of compounds.
- Methodologies for synthesizing or preparing the compound.
- Novel methods of formulation enhancing therapeutic efficiency.
- Specific delivery mechanisms, such as controlled release or targeted delivery systems.
2. Language and Boundaries
The scope is articulated through claims, which specify the breadth and limitations of the patent protection:
- Independent claims likely encapsulate the primary inventive concept, e.g., a pharmaceutical compound with a certain structure or a process with defined steps.
- Dependent claims extend this protection by adding particular parameters, such as specific substituents, dosage forms, or process modifications.
3. Technical Parameters and Limitations
The claims often specify:
- Structural formulas or chemical structures with permissible substitutions.
- Dosage ranges, formulations, or administration routes.
- Conditions under which the processes are performed (e.g., temperature, pH, catalysts).
This careful delineation ensures the patent's protection covers the core inventive concept while delimiting the scope against state-of-the-art and literature disclosures.
Claims Analysis
1. Independent Claims
Typically, independent claims establish the scope's foundation, e.g., a novel compound comprising specific structural features or a method for synthesizing such compounds with particular steps or catalysts. For example:
- Claim 1 might define a compound with a particular chemical backbone, substituted at certain positions.
- Claim 2 might describe a process for preparing said compound, emphasizing steps that confer novelty.
2. Dependent Claims
Dependent claims serve to refine and specify aspects like:
- The pharmacokinetic properties (e.g., improved half-life, bioavailability).
- Specific salt forms, polymorphs, or crystalline structures.
- Particular dosing regimens or drug delivery systems.
3. Possible Patent Claims Focus
Given the common strategies in pharmaceutical patents, claims likely focus on:
- Chemical novelty: new derivatives with improved efficacy.
- Manufacturing process: novel synthesis steps reducing costs or improving purity.
- Use claims: new therapeutic applications or methods of treatment.
- Formulation claims: delivery systems, stability-enhanced formulations, or combination therapies.
4. Claim Strategy and Patent Quality
The claims seem to balance breadth and specificity—covering essential aspects of the inventive concept while avoiding overbroad language that could risk invalidity. Well-defined claims fortify the patent amid potential challenges and enable enforceability.
Patent Landscape in South Korea for Similar Innovations
1. Kind of Patents and Prior Art
South Korea’s pharmaceutical patent landscape is highly active:
- A significant number of patents cover new chemical entities (NCEs), polymorphs, and formulations.
- The prior art includes older patents from international filings, especially from Major US/EU pharmaceutical firms, and Korean domestic patents.
2. Overlap and Potential Infringements
Given the active patenting environment, especially from firms like SK Chemical, Hanmi, and Dong-A, companies must carefully navigate around existing claims to avoid infringement or invalidity.
3. Patent Filing Trends
Recent trends indicate:
- Focus on biosimilars, targeted therapies, and drug delivery systems.
- Increased filings for polymorphs and formulations for known compounds, aimed at extending patent life or improving properties.
4. Patent Challenges and Litigation
South Korea’s patent courts rigorously examine inventive step and novelty:
- Challenges against similar patents often revolve around obviousness and claim scope.
- Patent opposition and invalidation procedures are common, emphasizing the importance of drafting precise claims.
Strategic Implications
For Patent Holders:
- Ensuring claims encompass both broad structural features and narrow, specific embodiments enhances enforceability.
- Maintaining thorough documentation of inventive steps secures patent strength.
For Competitors:
- Analyzing the patent landscape reveals potential freedom-to-operate issues.
- Identifying overlapping patents aids in designing around claims effectively.
For Legal Practitioners:
- Focus on claim clarity, avoiding overly broad language that risks invalidation.
- Stay updated on patent law developments, especially regarding inventive step and obviousness standards.
Key Takeaways
- Scope and Claims: Patent KR20140009332 covers specific chemical compounds or formulations, with claims structured to balance breadth and enforceability.
- Patent Landscape: South Korea maintains a dynamic pharmaceutical patent environment characterized by active filings in novel formulations, delivery systems, and chemical derivatives.
- Strategic Protection: Precise claims, careful claim drafting, and comprehensive patent landscapes are pivotal to securing meaningful protection and avoiding infringement.
- Innovation Opportunities: Stakeholders should continuously monitor new filings and litigation trends to optimize R&D focus and patent strategies.
FAQs
1. What is the primary inventive concept protected by KR20140009332?
It likely pertains to a novel chemical compound, formulation, or synthesis process with enhanced therapeutic properties, as disclosed in its claims.
2. How broad are the claims in this patent, and can they be challenged?
Depending on their language, claims may range from narrow (specific compounds/formulations) to broader (classes of compounds). Their robustness depends on inventive step and novelty, and they can be challenged through invalidation procedures.
3. How does the patent landscape in South Korea impact the lifecycle of pharmaceutical innovations?
South Korea’s active patent environment encourages continuous innovation but also promotes strategic patent filing, licensing, and possible litigations, influencing the lifecycle by extending exclusivity or prompting generics.
4. What strategies should companies adopt regarding similar patents?
Conduct comprehensive freedom-to-operate analyses, consider designing around existing claims, and seek opportunities for patent enhancements or secondary patents.
5. Can this patent be enforced beyond South Korea?
While it provides protection within South Korea, similar patents must be filed in other jurisdictions for international enforcement, unless the invention falls under international treaties like Patent Cooperation Treaty (PCT) applications.
Sources
- Korean Intellectual Property Office (KIPO) patent database.
- South Korean Patent Act and Examination Guidelines.
- Industry reports on pharmaceutical patenting in South Korea.
- Patent landscape analyses from legal consultancies specializing in biotech/IP law.
